Literature DB >> 22664630

What determines testosterone levels?

Jun Kawakami1, Premal Patel.   

Abstract

Entities:  

Year:  2012        PMID： 22664630      PMCID： PMC3367014          DOI： 10.5489/cuaj.12115

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  6 in total

1.  Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate.

Authors:  Seetha Venkateswaran; David Margel; Stanley Yap; Karen Hersey; Paul Yip; Neil Eric Fleshner
Journal:  Can Urol Assoc J       Date:  2012-06       Impact factor: 1.862

2.  Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

3.  Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.

Authors:  Karol Axcrona; Sirpa Aaltomaa; Carlos Martins da Silva; Haluk Ozen; Jan-Erik Damber; László B Tankó; Enrico Colli; Peter Klarskov
Journal:  BJU Int       Date:  2012-04-13       Impact factor: 5.588

4.  Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.

Authors:  Juan Morote; Anna Orsola; Jacques Planas; Enrique Trilla; Carles X Raventós; Lluís Cecchini; Roberto Catalán
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

5.  Serum testosterone suppression and potential for agonistic stimulation during chronic treatment with monthly and 3-month depot formulations of leuprolide acetate for advanced prostate cancer.

Authors:  Roohollah Sharifi; Robert Browneller
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

6.  LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion.

Authors:  Igle Jan de Jong; Alan Eaton; Franck Bladou
Journal:  Curr Med Res Opin       Date:  2007-05       Impact factor: 2.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.